Sign inJoin waitlistJoin the waitlist

Pedro Sanz-Altamira

Associate Medical Director, Dana-Farber – Merrimack Valley · Mass General Brigham

Credentials: · · · · ·

History

Dana-Farber – Merrimack Valley · Mass General Brigham
Present

Hematology and Medical Oncology
Beth Israel Deaconess Medical Center
1991–1994
Newton-Wellesley Hospital
1988–1991
Seville University Medical School
1984–1988

Research

Selective chemoembolization in the management of hepatic metastases in refractory colorectal carcinoma: a phase II trial
Diseases of the Colon & Rectum · 1997 · First of 7 authors · 85 citations
A phase II trial of 5-fluorouracil, leucovorin, and carboplatin in patients with unresectable biliary tree carcinoma
Cancer · 1998 · First of 6 authors · 83 citations
A phase II study of irinotecan in patients with advanced hepatocellular carcinoma
Cancer · 2001 · 53 citations

KS
Keith Stuart
4 papers
Paul Hesketh
3 papers
CB
Chiara Battelli
2 papers
EO
Eileen O'Reilly
2 papers
Erica Mayer
2 papers
LS
Leonard Saltz
2 papers
Leticia Varella
2 papers
MH
Mark Huberman
2 papers
Meredith Faggen
2 papers
NK
Nancy Kemeny
2 papers
Natalie Sinclair
2 papers
Philip Poorvu
2 papers

Clinical trials

Collection of Blood Specimens for Circulating Tumor Cell Analysis
Principal investigator · Completed
Viatar LLC
2013–2016
EQUAL: EGFR ctDNA QUantative Assessment for Lung Cancer Screening in Asian and Latinx Populations
Site PI · Recruiting
Dana-Farber Cancer Institute
2025–2030
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
Site PI · Recruiting · Phase 3
Alliance for Clinical Trials in Oncology
2025–2037
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Site PI · Recruiting · Phase 2
Alliance for Clinical Trials in Oncology
2025–2034